GlaxoSmithKline PLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
GlaxoSmithKline PLC
CIK #0001131399
EDGAR Form CIK 2011 - 2024
3 [0001131399]
4 [0001131399]
5 [0001131399]
6-K [0001131399]
SC 13D [0001131399]
SC 13G [0001131399]
Form 13D/13G Filer Form 13D/13G Subject Filed
GSK PLC CVRX Inc [2023-02-06]
GSK PLC Wave Life Sciences Ltd [2023-01-30]
GSK PLC 23Andme Holding Co [2022-11-04]
GSK PLC Haleon PLC [2022-07-27]
Dodge & Cox GlaxoSmithKline PLC [2022-02-14]
GlaxoSmithKline PLC Lyell Immunopharma Inc [2022-02-10]
GlaxoSmithKline PLC CVRX Inc [2021-07-12]
GlaxoSmithKline PLC F-Star Therapeutics Inc [2020-11-30]
GlaxoSmithKline PLC CureVac NV [2020-08-24]
GlaxoSmithKline PLC Pandion Therapeutics Inc [2020-08-03]
View All
Form 3/4/5 Subject 2011 - 2024
Wave Life Sciences Ltd.
GSK PLC
Spero Therapeutics, Inc.
23andMe Holding Co.
Theravance Biopharma, Inc.
CVRx, Inc.
Lyell Immunopharma, Inc.
Innoviva, Inc.
Decibel Therapeutics, Inc.
BICYCLE THERAPEUTICS plc
View All
Terms | Privacy | Guide
tony@aum13f.com